Protagenic Therapeutics
PTIX • NASDAQ
Protagenic Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Garo H. Armen, with a market cap of $2.5M.
CEOGaro H. Armen
Next Earnings
Upcoming earnings announcement for Protagenic Therapeutics
Date
Tuesday, May 12, 2026 (in a month)
Timing
Time TBD (3:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Protagenic Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q3 2025 | $1.14 | — | - | — |  10-Q |
| Nov 26, 2025 | Q2 2025 | -$0.47 | — | - | — | 10-Q |
| Sep 10, 2025 | Q2 2025 | -$1.37 | — | - | — | — |
| May 13, 2025 | Q1 2025 | -$2.75 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.24 | — | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.14 | — | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.36 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.39 | — | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.38 | — | - | — | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$0.32 | — | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.28 | — | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.17 | — | - | — | — |